These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28344162)

  • 1. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.
    Biswas C; Chen SC; Halliday C; Martinez E; Rockett RJ; Wang Q; Timms VJ; Dhakal R; Sadsad R; Kennedy KJ; Playford G; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    Garnaud C; Botterel F; Sertour N; Bougnoux ME; Dannaoui E; Larrat S; Hennequin C; Guinea J; Cornet M; Maubon D
    J Antimicrob Chemother; 2015 Sep; 70(9):2556-65. PubMed ID: 26017039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
    Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.
    Spettel K; Barousch W; Makristathis A; Zeller I; Nehr M; Selitsch B; Lackner M; Rath PM; Steinmann J; Willinger B
    PLoS One; 2019; 14(1):e0210397. PubMed ID: 30629653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.
    Imbert S; Castain L; Pons A; Jacob S; Meyer I; Palous M; Vezinet C; Langeron O; Hennequin C; Monsel A; Fekkar A
    Clin Microbiol Infect; 2016 Oct; 22(10):891.e5-891.e8. PubMed ID: 27484020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Genome Sequencing of Australian
    Biswas C; Marcelino VR; Van Hal S; Halliday C; Martinez E; Wang Q; Kidd S; Kennedy K; Marriott D; Morrissey CO; Arthur I; Weeks K; Slavin MA; Sorrell TC; Sintchenko V; Meyer W; Chen SC
    Front Microbiol; 2018; 9():2946. PubMed ID: 30559734
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
    Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
    Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
    J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
    Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel
    Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
    Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
    Chapeland-Leclerc F; Hennequin C; Papon N; Noël T; Girard A; Socié G; Ribaud P; Lacroix C
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1360-2. PubMed ID: 20038613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Khalifa HO; Arai T; Majima H; Watanabe A; Kamei K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.